share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

SEC announcement ·  Apr 18 17:17
Summary by Moomoo AI
Blake Borgeson, a reporting person associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of Class A Common Stock on April 16, 2024. The shares were sold at a price of $7.6636 per share, resulting in a total transaction value of $87,725.23. Following the transaction, Borgeson directly holds a total of 7,229,861 shares in the company. The sale was conducted in the open market.
Blake Borgeson, a reporting person associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of Class A Common Stock on April 16, 2024. The shares were sold at a price of $7.6636 per share, resulting in a total transaction value of $87,725.23. Following the transaction, Borgeson directly holds a total of 7,229,861 shares in the company. The sale was conducted in the open market.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more